Aeterna Zentaris(AEZS) - 2024 Q2 - Quarterly Report

Exhibit 99.1 COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) Condensed Interim Consolidated Financial Statements As of June 30, 2024, and for the three and six months ended June 30, 2024, and 2023 (In thousands of US dollars) (Unaudited) | Condensed Interim Consolidated Statements of Financial Position | 2 | | --- | --- | | Condensed Interim Consolidated Statements of Changes in Shareholders' Equity | 3 | | Condensed Interim Consolidated Statements of Loss and Comprehensive Loss | 4 | | Condensed I ...